Overview

Non Invasive Prenatal Testing Market is poised to register a CAGR of 18.1% during the forecast period 2022 to 2028.

In non-invasive prenatal testing (NIPT), blood samples from a pregnant woman are tested for abnormalities within the fetus. Test results are analyzed using DNA fragments from the mother's blood in order to diagnose genetic disorders such as Down syndrome , Edwards syndrome , Patau syndrome, and Turner syndrome. This procedure eliminates the need for chorionic villus sampling (CVS), an invasive and precarious procedure, and can be performed at any time after nine weeks of pregnancy. There are growing numbers of genetic disorders of the fetus, which is one of the key factors driving the market's growth. Furthermore, technological advancements in the life sciences and healthcare industries are also driving the market. As an example, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have opened up immense possibilities to combat any serious disease at its earliest stages. Also driving the growth of the market are rising health consciousness and awareness about the importance and benefits of prenatal testing, as well as increasing acceptance and acceptance rates of such tests. It is becoming more common for healthcare providers, as well as expecting parents, to use alternative diagnostic methods to diagnose and treat other genetic disorders, such as spina bifida, cleft palate, and sickle cell anemia. Additionally, the shifting trend toward childbearing at a high maternal age is positively impacting the market growth. There are a number of health complications that can occur as a mother's age advances. These complications can include high blood pressure, reduced fertility, miscarriage risk, and chromosomal abnormalities in the fetus.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Non Invasive Prenatal Testing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Non Invasive Prenatal Testing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Non Invasive Prenatal Testing (NIPT) Market:
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Bgi
• Agilent Technologies, Inc.
• F. Hoffmann-La Roche Ltd.
• PerkinElmer Inc.
• Laboratory Corporation of America Holdings
• Natera, Inc.
• Yourgene Health
(Note: The list of the major players will be updated with the latest market scenario and trends)

Non Invasive Prenatal Testing Market Segmentation:
By Product & Service
• Products
  o Consumables
    o Assay Kits & Reagents
    o  Disposables
  o Instruments
    o  Ultrasound Devices
    o Next-Generation Sequencing Systems
    o Polymerase Chain Reaction Instruments
    o  Microarrays
    o  Other Instruments
• Services

By Method 
• Ultrasound Detection
• Biochemical Screening Tests
• Cell-free DNA in Maternal Plasma Tests

By Application 
• Trisomy
• Microdeletion Syndrome
• Other Applications

By End User
• Diagnostic Laboratories
• Hospitals

By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Non Invasive Prenatal Testing Market By Product & Service, By Method, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansion

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics